# FDA Warning Letter: Ozempen.com
> 2024-07-02 · Center for Drug Evaluation and Research | CDER · `ca2f02965dc37ebe`
## Letter
- **Company:** Ozempen.com
- **Posted Date:** 2024-07-02
- **Letter Issue Date:** 2024-06-24
- **Issuing Office:** Center for Drug Evaluation and Research | CDER
## Subject
Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*